Main determinants of PON1 activity in hemodialysis patients.

作者: Sandra Ribeiro , Maria do Sameiro Faria , Filipa Mascarenhas-Melo , Isabel Freitas , Maria Isabel Mendonça

DOI: 10.1159/000342235

关键词:

摘要: Background/Aims: Cardiovascular diseases are the major cause of morbidity and mortality in hemodialysis (HD) patients. These patients present reduced paraoxonase

参考文章(22)
Francesco Locatelli, Pedro Aljama, Peter Bárány, Bernard Canaud, Fernando Carrera, Kai-Uwe Eckardt, Walter H Hörl, Iain C Macdougal, Alison Macleod, Andrzej Wiecek, Stewart Cameron, European Best Practice Guidelines Working Group, Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrology Dialysis Transplantation. ,vol. 19, pp. 1- 47 ,(2004) , 10.1093/NDT/GFH1032
Bernhard F. Henning, Helge Holzhausen, Martin Tepel, Continuous Reduction of Plasma Paraoxonase Activity With Increasing Dialysis Vintage in Hemodialysis Patients Therapeutic Apheresis and Dialysis. ,vol. 14, pp. 572- 576 ,(2010) , 10.1111/J.1744-9987.2010.00844.X
Judit Marsillach, Albert Martínez-Vea, Luis Marcas, Bharti Mackness, Michael Mackness, Natàlia Ferré, Jorge Joven, Jordi Camps, ADMINISTRATION OF EXOGENOUS ERYTHROPOIETIN β AFFECTS LIPID PEROXIDATION AND SERUM PARAOXONASE-1 ACTIVITY AND CONCENTRATION IN PREDIALYSIS PATIENTS WITH CHRONIC RENAL DISEASE AND ANAEMIA Clinical and Experimental Pharmacology and Physiology. ,vol. 34, pp. 347- 349 ,(2007) , 10.1111/J.1440-1681.2007.04552.X
C. Schrader, G. Rimbach, Determinants of Paraoxonase 1 Status: Genes, Drugs and Nutrition Current Medicinal Chemistry. ,vol. 18, pp. 5624- 5643 ,(2011) , 10.2174/092986711798347216
Marija Grdić Rajković, Karmela Barišić, Dubravka Juretić, Tihana Žanić Grubišić, Zlata Flegar-Meštrić, Lada Rumora, Polymorphisms of pon1 and pon2 genes in hemodialyzed patients Clinical Biochemistry. ,vol. 44, pp. 964- 968 ,(2011) , 10.1016/J.CLINBIOCHEM.2011.05.012
Maria F. Lopes-Virella, Gabriel Virella, Clinical significance of the humoral immune response to modified LDL Clinical Immunology. ,vol. 134, pp. 55- 65 ,(2010) , 10.1016/J.CLIM.2009.04.001
D Atchley, M Lopes-Virella, D Zheng, D Kenny, G Virella, None, Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy. Diabetologia. ,vol. 45, pp. 1562- 1571 ,(2002) , 10.1007/S00125-002-0962-Y
Elżbieta Kimak, Magdalena Hałabiś, Iwona Baranowicz-Gąszczyk, Janusz Solski, Andrzej Książek, Association between moderately oxidized low-density lipoprotein and high-density lipoprotein particle subclass distribution in hemodialyzed and post-renal transplant patients Journal of Zhejiang University SCIENCE B. ,vol. 12, pp. 365- 371 ,(2011) , 10.1631/JZUS.B1000348
D L Rainwater, S Rutherford, T D Dyer, E D Rainwater, S A Cole, J L VandeBerg, L Almasy, J Blangero, J W MacCluer, M C Mahaney, Determinants of variation in human serum paraoxonase activity Heredity. ,vol. 102, pp. 147- 154 ,(2009) , 10.1038/HDY.2008.110